NASDAQ:IBB - iShares Nasdaq Biotechnology ETF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$149.21
▲ +2.07 (1.41%)
1 month | 3 months | 12 months
Get New iShares Nasdaq Biotechnology ETF Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IBB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IBB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for iShares Nasdaq Biotechnology ETF in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $149.21.
N/A
The current consensus among 0 investment analysts is to n/a stock in iShares Nasdaq Biotechnology ETF. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/12/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/11/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/10/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/8/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/6/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/3/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/5/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/21/2017Credit Suisse GroupUpgradeMarket Weight ➝ OverweightHigh
i
(Data available from 3/5/2016 forward)
iShares Nasdaq Biotechnology ETF logo
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.
Read More

Today's Range

Now: $149.21
$142.52
$149.30

50 Day Range

MA: $163.93
$150.77
$172.60

52 Week Range

Now: $149.21
$92.15
$174.04

Volume

534,166 shs

Average Volume

3,062,930 shs

Market Capitalization

$10.09 billion

P/E Ratio

N/A

Dividend Yield

0.21%

Beta

1.07

Frequently Asked Questions

What sell-side analysts currently cover shares of iShares Nasdaq Biotechnology ETF?

The following Wall Street analysts have issued stock ratings on iShares Nasdaq Biotechnology ETF in the last year:
View the latest analyst ratings for IBB.

What is the current price target for iShares Nasdaq Biotechnology ETF?

0 Wall Street analysts have set twelve-month price targets for iShares Nasdaq Biotechnology ETF in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for iShares Nasdaq Biotechnology ETF in the next year.
View the latest price targets for IBB.

What is the current consensus analyst rating for iShares Nasdaq Biotechnology ETF?

iShares Nasdaq Biotechnology ETF currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for IBB.

What other companies compete with iShares Nasdaq Biotechnology ETF?